Derma Sciences (DSCI) Posts Q1 Loss of 24c/Share, Misses by 8c
Get Alerts DSCI Hot Sheet
Join SI Premium – FREE
Derma Sciences (NASDAQ: DSCI) reported Q1 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $16.33 million.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share